
Bemfola - European Medicines Agency (EMA)
2014年5月16日 · Bemfola is a medicine that contains the active substance follitropin alfa. It is used to treat the following groups: women who are undergoing assisted reproductive techniques (fertility treatment) such as fertilisation. Bemfola is given to stimulate the ovaries to produce more than one egg at a time;
Bemfola is intended for subcutaneous use. The injection should be given at the same time each day. The first injection of Bemfola should be performed under direct medical supervision. Self-administration of Bemfola should only be performed by patients who are well motivated, adequately trained and have access to expert advice.
Bemfola is a medicine that contains the active substance follitropin alfa. It is used to treat the following groups: • women who are undergoing assisted reproductive techniques (fertility treatment) such as in vitro fertilisation. Bemfola is given to stimulate the ovaries to produce more than one egg at a time;
- [PDF]
Bemfola® - Medsafe
Bemfola belongs to a class of hormones called gonadotrophins. FSH is necessary for the growth and development of egg cells (follicles) in women, and sperm production in men. Bemfola is an approved biosimilar to the reference product Gonal-f®. Comparability in safety, efficacy and quality between Bemfola and Gonal-f® have been established. In ...
Bemfola 75 IU/0.125 mL, 150 IU/0.25 mL, 225 IU/0.375 mL, 300 …
2024年2月15日 · Bemfola should be given at a dose of 150 IU three times a week, concomitantly with hCG, for a minimum of 4 months. If after this period, the patient has not responded, the combination treatment may be continued; current clinical experience indicates that treatment for at least 18 months may be necessary to achieve spermatogenesis.
Bemfola (follitropin alfa), solution for injection in pre-filled pen. Prescription medicine. What Bemfola is used for: Adult women: 1) to help release an egg from the ovary (ovulation) in women that cannot ovulate and that did not respond to treatment with a medicine
Bemfola - Gedeon Richter Plc. - 药物在线
In adult women: anovulation (including polycystic ovarian disease, PCOD) in women who have been unresponsive to treatment with clomiphene citrate; stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIF...
Bemfola: Uses, Dosage, Side Effects, Food Interaction & FAQ
2025年1月7日 · Used for the treatment of female infertility, Bemfola beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Bemfola beta is the primary hormone responsible for follicular recruitment and development.
Bemfola - patient leaflet, side effects, dosage
In adult women , Bemfola is used: to help release an egg from the ovary (ovulation) in women that cannot ovulate and that did not respond to treatment with a medicine called “clomiphene citrate”. release an egg from the ovary (ovulation) in women that are not ovulating because their body is producing very little gonadotropins (FSH and LH).
Gamme de médicaments BEMFOLA - VIDAL
Ce médicament est un médicament biosimilaire de GONAL-F. Dans quel cas le médicament BEMFOLA est-il prescrit ? Ce médicament contient une hormone (FSH) de la famille des gonadotrophines, obtenue par biotechnologie. Naturellement présente dans l'organisme, la FSH participe au contrôle des organes de la reproduction.